These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8113837)

  • 1. Prognostic importance of restaging gallium scans following induction chemotherapy for advanced Hodgkin's disease.
    King SC; Reiman RJ; Prosnitz LR
    J Clin Oncol; 1994 Feb; 12(2):306-11. PubMed ID: 8113837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early restaging gallium scans predict outcome in poor-prognosis patients with aggressive non-Hodgkin's lymphoma treated with high-dose CHOP chemotherapy.
    Janicek M; Kaplan W; Neuberg D; Canellos GP; Shulman LN; Shipp MA
    J Clin Oncol; 1997 Apr; 15(4):1631-7. PubMed ID: 9193363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mid- and post-ABVD gallium scanning predicts for recurrence in early-stage Hodgkin's disease.
    Ng AK; Bernardo MV; Silver B; Van Den Abbeele A; Stevenson MA; Fisher DC; Mauch PM
    Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):175-84. PubMed ID: 15629609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restaging with gallium scan identifies chemosensitive patients and predicts survival of poor-prognosis mediastinal Hodgkin's disease patients.
    Ionescu I; Brice P; Simon D; Guermazi A; Leblanc T; Rousselot P; Gossot D; Meignin V; Gisselbrecht C; Rain JD
    Med Oncol; 2000 May; 17(2):127-34. PubMed ID: 10871819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hodgkin's disease: prognostic role of gallium scintigraphy after chemotherapy.
    Brenot-Rossi I; Bouabdallah R; Di Stefano D; Bardou VJ; Stoppa AM; Camerlo J; Sauvan R; Gastaut JA; Pasquier J
    Eur J Nucl Med; 2001 Oct; 28(10):1482-8. PubMed ID: 11685490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of gallium scan, computed tomography, and magnetic resonance in patients with mediastinal Hodgkin's disease.
    Devizzi L; Maffioli L; Bonfante V; Viviani S; Balzarini L; Gasparini M; Valagussa P; Bombardieri E; Santoro A; Bonadonna G
    Ann Oncol; 1997; 8 Suppl 1():53-6. PubMed ID: 9187430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gallium scan in adolescents and children with Hodgkin's disease (HD). Treatment response assessment and prognostic value.
    Castellani MR; Cefalo G; Terenziani M; Aliberti G; Maccauro M; Alessi A; Villano C; Bombardieri E
    Q J Nucl Med; 2003 Mar; 47(1):22-30. PubMed ID: 12714951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gallium-67 scans as an adjunct to computed tomography scans for the assessment of a residual mediastinal mass in pediatric patients with Hodgkin's disease. A Pediatric Oncology Group study.
    Weiner M; Leventhal B; Cantor A; Wimmer R; Berry DL; Cook B; Ducos R
    Cancer; 1991 Dec; 68(11):2478-80. PubMed ID: 1933785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gallium scans in patients with mediastinal Hodgkin's disease treated with chemotherapy.
    Cooper DL; Caride VJ; Zloty M; Germino J; Farber LR; Hoffer PB
    J Clin Oncol; 1993 Jun; 11(6):1092-8. PubMed ID: 8501495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gallium scanning in the management of mediastinal Hodgkin's disease.
    Wylie BR; Southee AE; Joshua DE; McLaughlin AF; Gibson J; Hutton BF; Morris JG; Kronenberg H
    Eur J Haematol; 1989 Apr; 42(4):344-7. PubMed ID: 2721659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positron emission tomography scanning in the assessment of patients with lymphoma.
    Foo SS; Mitchell PL; Berlangieri SU; Smith CL; Scott AM
    Intern Med J; 2004 Jul; 34(7):388-97. PubMed ID: 15271172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gallium scans in the evaluation of residual masses after chemotherapy for seminoma.
    Warren GP; Einhorn LH
    J Clin Oncol; 1995 Nov; 13(11):2784-8. PubMed ID: 7595739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gallium scans in the management of patients with Hodgkin's disease: a study of 101 patients.
    Salloum E; Brandt DS; Caride VJ; Cornelius E; Zelterman D; Schubert W; Mannino T; Cooper DL
    J Clin Oncol; 1997 Feb; 15(2):518-27. PubMed ID: 9053473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of primary progressive Hodgkin's and aggressive non-Hodgkin's lymphoma: is there a chance for cure?
    Josting A; Reiser M; Rueffer U; Salzberger B; Diehl V; Engert A
    J Clin Oncol; 2000 Jan; 18(2):332-9. PubMed ID: 10637247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
    Fu XH; Wang SS; Huang Y; Wang B; Huang HQ; Zhang L; Sun XF; Xu RH; Lin TY
    Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic impact of pretransplantation computed tomography and gallium scans in patients with Hodgkin lymphoma with poor prognosis undergoing hematopoietic stem cell transplantation.
    Escobar IG; Barrigon DC; Tamayo P; Perez-Simon JA; Mateos MV; Garcia JR; San Miguel JF
    Clin Lymphoma Myeloma; 2006 Nov; 7(3):217-25. PubMed ID: 17229338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of PET using 18F-FDG in Hodgkin's disease for posttreatment evaluation.
    Guay C; Lépine M; Verreault J; Bénard F
    J Nucl Med; 2003 Aug; 44(8):1225-31. PubMed ID: 12902411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-photon emission computed tomography gallium imaging versus computed tomography: predictive value in patients undergoing high-dose chemotherapy and autologous stem-cell transplantation for non-Hodgkin's lymphoma.
    Vose JM; Bierman PJ; Anderson JR; Harrison KA; Dalrymple GV; Byar K; Kessinger A; Armitage JO
    J Clin Oncol; 1996 Sep; 14(9):2473-9. PubMed ID: 8823325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gallium scan in the evaluation of post chemotherapy mediastinal residual masses of aggressive non-Hodgkin's lymphoma.
    Ulusakarya A; Lumbroso J; Casiraghi O; Koscielny S; Vantelon JM; Girinsky T; Tardivon A; Bourhis JH; Dartevelle P; Pico JL; Munck JN
    Leuk Lymphoma; 1999 Nov; 35(5-6):579-86. PubMed ID: 10609795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intensive chemotherapy and low-dose radiotherapy for the treatment of advanced-stage Hodgkin's disease in pediatric patients: a Pediatric Oncology Group study.
    Weiner MA; Leventhal BG; Marcus R; Brecher M; Ternberg J; Behm FG; Cantor A; Wharam M; Chauvenet A
    J Clin Oncol; 1991 Sep; 9(9):1591-8. PubMed ID: 1714950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.